We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+11.07%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$48.8B
AUM Growth
+$7.31B
(+18%)
Cap. Flow
+$2.97B
Cap. Flow
% of AUM
6.1%
Top 10 Holdings %
Top 10 Hldgs %
18.45%
Holding
760
New
71
Increased
309
Reduced
252
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$305M |
| 2 |
CVS Health
CVS
|
+$190M |
| 3 |
Novartis
NVS
|
+$175M |
| 4 |
Broadcom
AVGO
|
+$154M |
| 5 |
Western Digital
WDC
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halliburton
HAL
|
+$260M |
| 2 |
UnitedHealth
UNH
|
+$217M |
| 3 |
United Parcel Service
UPS
|
+$140M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$137M |
| 5 |
McKesson
MCK
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.38% |
| 2 | Healthcare | 15.25% |
| 3 | Technology | 13.09% |
| 4 | Industrials | 10.62% |
| 5 | Energy | 10.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Group 1 Automotive
GPI
$3.94B
| $21M | 0.04% |
295,898
-6,386
| -2% | -$435K |
|
277
Keurig Dr Pepper
KDP
$40.4B
| $20.6M | 0.04% |
423,380
-71,614
| -14% | -$3.37M |
|
|
AMSG
278
DELISTED
Amsurg Corp
AMSG
| $20.5M | 0.04% |
445,723
-5,242
| -1% | -$232K |
|
279
Upbound Group
UPBD
$1.19B
| $20.3M | 0.04% |
610,231
-11,667
| -2% | -$404K |
|
280
FerroAtlántica
GSM
$628M
| $20M | 0.04% |
1,108,569
-549,139
| -33% | -$9.45M |
|
281
WSFS Financial
WSFS
$4.1B
| $19.9M | 0.04% |
769,845
+63,750
| +9% | +$1.49M |
|
282
Stagwell
STGW
$1.84B
| $19.9M | 0.04% |
779,515
-215,750
| -22% | -$4.67M |
|
283
AstraZeneca
AZN
$263B
| $19.7M | 0.04% |
331,935
-2,294,117
| -87% | -$125M |
|
|
MYCC
284
DELISTED
ClubCorp Holdings, Inc.
MYCC
| $19.7M | 0.04% |
+1,110,000
| New | +$17M |
|
285
LCI Industries
LCII
$2.51B
| $19.5M | 0.04% |
381,280
-5,696
| -1% | -$290K |
|
286
Orion Group Holdings
ORN
$514M
| $19.4M | 0.04% |
1,611,098
+20,176
| +1% | +$235K |
|
287
Walker & Dunlop
WD
$1.65B
| $19.4M | 0.04% |
1,197,831
+137,161
| +13% | +$1.97M |
|
288
The GEO Group
GEO
$4.13B
| $19.1M | 0.04% |
887,355
+227,910
| +35% | +$5.11M |
|
|
ACH
289
Accendra Health
ACH
$240M
| $19M | 0.04% |
518,921
-12,848
| -2% | -$472K |
|
|
EFII
290
DELISTED
Electronics for Imaging
EFII
| $18.9M | 0.04% |
489,065
-21,737
| -4% | -$791K |
|
291
Regions Financial
RF
$26.3B
| $18.8M | 0.04% |
1,904,500
+679,835
| +56% | +$6.55M |
|
|
AEL
292
DELISTED
American Equity Investment Life Holding Company
AEL
| $18.7M | 0.04% |
710,055
-88,140
| -11% | -$2.01M |
|
|
UTEK
293
DELISTED
Ultratech Inc.
UTEK
| $18.7M | 0.04% |
644,870
+55,630
| +9% | +$1.48M |
|
294
Stride
LRN
$3.69B
| $18.6M | 0.04% |
854,844
+702,259
| +460% | +$14.6M |
|
295
Granite Construction
GVA
$5.45B
| $18.5M | 0.04% |
528,572
+188,945
| +56% | +$5.94M |
|
296
CDW
CDW
$17.1B
| $17.8M | 0.04% |
760,212
+306,685
| +68% | +$6.88M |
|
297
Baidu
BIDU
$35.8B
| $17.7M | 0.04% |
99,229
-28,199
| -22% | -$4.56M |
|
|
BRS
298
DELISTED
Bristow Group, Inc.
BRS
| $17.6M | 0.04% |
233,873
-17,583
| -7% | -$1.37M |
|
|
ISCA
299
DELISTED
International Speedway Corp
ISCA
| $17.5M | 0.04% |
493,690
-149,346
| -23% | -$5M |
|
300
Petrobras Class A
PBR.A
$107B
| $17.3M | 0.04% |
1,177,809
+504,766
| +75% | +$8.31M |
|
Similar funds
Boston Partners's Q4 2013 Portfolio in Review
As of Q4 2013, Boston Partners held 760 positions worth $48.8B, up 18% from $41.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Boston Partners deployed $2.97B of net new capital in Q4 2013, opening 71 new positions and adding to 309 existing holdings. Its largest new stake was Novartis: 2,524,138 shares worth $182M.
By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Halliburton, an estimated $260M trimmed.
- Boston Partners's largest Q4 2013 buy was Novartis: 2,524,138 shares worth $182M.
- Boston Partners added most to ExxonMobil in Q4 2013, an estimated $305M increase.
- Boston Partners's biggest Q4 2013 reduction was Halliburton, cutting an estimated $260M.
- Boston Partners fully exited NVIDIA in Q4 2013, selling an estimated $131M.
- Boston Partners's ten largest holdings make up 18% of its $48.8B portfolio in Q4 2013.
- Boston Partners opened 71 new positions and closed 53 in Q4 2013.
- Boston Partners's portfolio value rose 18% quarter-over-quarter to $48.8B.
Based on Boston Partners's 13F filing for Q4 2013, filed 6 Feb 2014.